Efficacy of a reverse-phase polymer as a submucosal injection solution for EMR: a comparative study (with video)

Introduction Reverse-phase polymers undergo a temperature-dependent liquid-to-gel transition that may provide a more durable cushion for EMR and could yield improvements in safety and efficacy. Objective Our purpose was to assess the efficacy of poloxamer solution PS137-25 as a submucosal injection....

Full description

Saved in:
Bibliographic Details
Published inGastrointestinal endoscopy Vol. 69; no. 6; pp. 1135 - 1139
Main Authors Fernández-Esparrach, Gloria, MD, PhD, Shaikh, Sohail N., MD, Cohen, Arielle, BS, Ryan, Michele B., MS, Thompson, Christopher C., MD, MSc, FACG, FASGE
Format Journal Article Reference
LanguageEnglish
Published Maryland heights, MO Mosby, Inc 01.05.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Introduction Reverse-phase polymers undergo a temperature-dependent liquid-to-gel transition that may provide a more durable cushion for EMR and could yield improvements in safety and efficacy. Objective Our purpose was to assess the efficacy of poloxamer solution PS137-25 as a submucosal injection. Design Comparative study among 3 different solutions for EMR using ex vivo and in vivo porcine models. Interventions A total of 120 gastric submucosal cushions were performed in fresh ex vivo porcine stomachs with saline solution 0.9% (n = 40), hydroxypropyl methylcellulose (HPMC) (n = 40), and PS137-25 (n = 40). Five in vivo porcine colon EMRs were then performed. Main Outcome Measurements Height and duration of submucosal cushions were measured in the ex vivo model, and the usefulness of reverse-phase polymers was assessed by in vivo en bloc resection. Results Ex vivo: The height of mucosal elevation was greater with PS137-25 (10.3 ± 2.2 mm) than with saline solution (8.3 ± 2.6 mm) or HPMC (9.05 ± 2.3 mm, not significant). All submucosal elevations with PS137-25 lasted longer (more than 20 minutes) than with saline solution (20.9 ± 11 minutes, P < .01) or HPMC (89 ± 32 minutes, P < .01). After 120 minutes, the elevations obtained with PS137-25 showed no differences in size, shape, or consistency from initial measurements. In vivo: All 5 EMRs were successfully performed after 1 injection of PS137-25. No repeat injections were needed. During resection, a large gel cushion was noted. Conclusions Mucosal elevation with PS137-25 is more durable than with other substances, with no changes in size or consistency observed over 120 minutes. Additionally, reverse-phase polymers performed well in in vivo colon EMRs. These results suggest that reverse-phase polymers may provide increased safety and efficacy for EMR procedures.
Bibliography:SourceType-Other Sources-1
ObjectType-Reference Document-1
content type line 57
ObjectType-Instructional Material/Guideline-2
ObjectType-Article-3
ISSN:0016-5107
1097-6779
DOI:10.1016/j.gie.2008.07.032